"Methyldopa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
| Descriptor ID |
D008750
|
| MeSH Number(s) |
D02.092.311.200.538 D12.125.072.050.685.400.600 D12.125.072.050.875.130.600
|
| Concept/Terms |
Methyldopa- Methyldopa
- alpha-Methyl-L-Dopa
- alpha Methyl L Dopa
- alpha-Methyldopa
- alpha Methyldopa
- Alphamethyldopa
|
Below are MeSH descriptors whose meaning is more general than "Methyldopa".
Below are MeSH descriptors whose meaning is more specific than "Methyldopa".
This graph shows the total number of publications written about "Methyldopa" by people in this website by year, and whether "Methyldopa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methyldopa" by people in Profiles.
-
Parkinson's disease and movement disorders: moving forward. Lancet Neurol. 2008 Jan; 7(1):9-11.
-
[Treatment effectiveness of hypertension during pregnancy]. Rev Assoc Med Bras (1992). 2006 Nov-Dec; 52(6):390-4.
-
An unexpected finding. Am J Med. 2005 May; 118(5):477-9.
-
Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa. Pharm Res. 1989 Jan; 6(1):66-70.
-
[Medical treatment of complete urinary retention with alpha blockaders]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1983 May-Jun; 32(3):161-8.
-
Drug-induced fever: cases seen in the evaluation of unexplained fever in a general hospital population. Rev Infect Dis. 1982 Jan-Feb; 4(1):69-77.
-
Conversion of catalase to the secondary catalase-peroxide complex (compound II) by alpha-methyldopa. Mol Pharmacol. 1981 Jul; 20(1):159-64.
-
Uropharmacology: XI. Adrenergic-blocking agents and drugs affecting catecholamine binding and release. Urology. 1979 Jun; 13(6):693-700.